Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on oncology and obesity therapeutics. Its pipeline includes CRB-701, a next-generation Nectin-4-targeting antibody drug conjugate (ADC) delivering MMAE payload for solid tumors, and CRB-913, a peripherally restricted CB1 receptor inverse agonist for obesity treatment. The company licenses CRB-701 from CSPC and conducts Phase 1/2 clinical trials in the U.S. and Europe.
expected 2026-12-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-098530 | EDGAR | 71K words |
| 2025-03-11 | 2024-12-31 | 0000950170-25-037335 | EDGAR | 70K words |
| 2024-03-12 | 2023-12-31 | 0000950170-24-030133 | EDGAR | 72K words |
| 2023-03-07 | 2022-12-31 | 0000950170-23-006469 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0000950170-22-003145 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001493152-21-006016 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001493152-20-004077 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001493152-19-003143 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001493152-18-003208 | EDGAR | — |
| 2017-03-08 | 2016-12-31 | 0001493152-17-002256 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-338274 | EDGAR | 19K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277748 | EDGAR | 19K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103118 | EDGAR | 18K words |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064507 | EDGAR | 15K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123486 | EDGAR | 21K words |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091922 | EDGAR | 20K words |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054625 | EDGAR | 17K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060377 | EDGAR | 24K words |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039960 | EDGAR | 24K words |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019825 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023282 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016150 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-14 | 0001193125-26-389829 | EDGAR | 2K words |
| 2026-08-06 | 0001193125-26-336864 | EDGAR | 3K words |
| 2026-03-09 | 0001193125-26-097582 | EDGAR | 2K words |
| 2026-02-25 | 0001193125-26-068566 | EDGAR | 4K words |
| 2026-01-12 | 0001193125-26-009758 | EDGAR | 4K words |
| 2025-12-18 | 0001193125-25-324796 | EDGAR | 1K words |
| 2025-12-11 | 0001193125-25-315039 | EDGAR | 4K words |
| 2025-11-12 | 0001193125-25-276062 | EDGAR | 3K words |
| 2025-11-03 | 0001193125-25-261722 | EDGAR | 1K words |
| 2025-10-30 | 0001193125-25-258692 | EDGAR | 1K words |
263 total filings indexed. 231 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001595097 |
| Ticker | CRBP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.corbuspharma.com |
| Listed | 2014-10-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CRBP (~200 tokens, structured JSON with cryptographic provenance)